This proposal focuses on characterizing the role of microglial toll-like receptor-4 (TLR4) in ischemic preconditioning (IPC). IPC is a robust neuroprotective phenomenon in which a brief period of cerebral ischemia confers transient tolerance to subsequent ischemic challenge. Characterization of the cellular and molecular mechanisms that underlie IPC is an important and active area of investigation in stroke research. Inflammatory responses in the brain are critical in the pathophysiology of stroke. Microglia, the brain's resident tissue macrophages, are central in this process. TLRs mediate powerful immune responses to a variety of pathogen associated molecular patterns including lipopolysaccharide (LPS). TLR4, which is expressed by microglia in the CNS, has been directly implicated in the pathophysiology of stroke. However, the role of microglial TLR4 signaling in IPC is unknown. Here we hypothesize that microglial TLR4 signaling is required for both optimal IPC-mediated neuroprotection and IPC-mediated attenuation of inflammatory responses seen in subsequent prolonged ischemia (stroke). We further postulate that hypoxia-inducible factor-11 (HIF-11), a central regulator of gene expression under low oxygen tension, is critical in mediating the effects of microglial TLR4 signaling on IPC. To test these hypotheses, we will first use a well-established in vivo model of stroke/IPC (mouse middle cerebral artery occlusion/reperfusion paradigm) on TLR4 knockout and control mice. We will assess infarct volume and neurobehavioral outcome. Then we will use ex vivo flow cytometry to characterize the inflammatory infiltrate and microglial phenotype in ischemic cortex following stroke alone, IPC alone or IPC followed by stroke. Second, we will carry out in vitro ischemia experiments on cultured primary microglia from TLR4 knockout and control mice to characterize the role of TLR4 signaling in modulating the microglial response to hypoxia/hypoglycemia. Third, we will use a myeloid-cell targeted, HIF-11 knockdown mouse strain, in addition to the systemic TLR4 knockout strain, to investigate in vivo the role of HIF-11 in mediating the effects of microglial TLR4 signaling on IPC. The results of these studies will be valuable to researchers trying to elucidate the cellular and molecular mechanisms of IPC, neuroinflammation and stroke. It will provide key insights into the pathophysiologic state of microglia in the ischemic penumbra and identify molecular targets for therapeutic intervention in acute stroke.

Public Health Relevance

Stroke is the leading cause of serious long-term disability and the third leading cause of death in the United States. Currently available pharmacologic therapies for acute stroke are few in number and limited by temporal restrictions on their use, modest efficacy and potential for serious side effects. A major goal of this research project is to increase our mechanistic understanding of stroke pathophysiology. By doing so, we hope to identify novel cellular and molecular targets for therapeutic intervention in acute stroke.

Agency
National Institute of Health (NIH)
Institute
National Institute of Neurological Disorders and Stroke (NINDS)
Type
Research Scientist Development Award - Research (K02)
Project #
1K02NS065008-01A1
Application #
7787154
Study Section
NST-2 Subcommittee (NST)
Program Officer
Utz, Ursula
Project Start
2009-09-01
Project End
2014-08-31
Budget Start
2009-09-01
Budget End
2010-08-31
Support Year
1
Fiscal Year
2009
Total Cost
$180,814
Indirect Cost
Name
University of Washington
Department
Neurology
Type
Schools of Medicine
DUNS #
605799469
City
Seattle
State
WA
Country
United States
Zip Code
98195
McDonough, Ashley; Lee, Richard V; Noor, Shahani et al. (2017) Ischemia/Reperfusion Induces Interferon-Stimulated Gene Expression in Microglia. J Neurosci 37:8292-8308
Janova, Hana; Böttcher, Chotima; Holtman, Inge R et al. (2016) CD14 is a key organizer of microglial responses to CNS infection and injury. Glia 64:635-49
Weinstein, Jonathan R; Quan, Yi; Hanson, Josiah F et al. (2015) IgM-Dependent Phagocytosis in Microglia Is Mediated by Complement Receptor 3, Not Fc?/? Receptor. J Immunol 195:5309-17
Hamner, Margaret A; Ye, Zucheng; Lee, Richard V et al. (2015) Ischemic Preconditioning in White Matter: Magnitude and Mechanism. J Neurosci 35:15599-611
Becker, Kyra J; Dankwa, Dorender; Lee, Richard et al. (2014) Stroke, IL-1ra, IL1RN, infection and outcome. Neurocrit Care 21:140-6
Weinstein, Jonathan R; Schulze, Juliane; Lee, Richard V et al. (2014) Functional polymorphisms in toll-like receptor 4 are associated with worse outcome in acute ischemic stroke patients. Neuroreport 25:580-4
Marder, C P; Donohue, M M; Weinstein, J R et al. (2012) Multimodal imaging of reversible cerebral vasoconstriction syndrome: a series of 6 cases. AJNR Am J Neuroradiol 33:1403-10
Creutzfeldt, Claire J; Becker, Kyra J; Weinstein, Jonathan R et al. (2011) Do-not-attempt-resuscitation orders and prognostic models for intraparenchymal hemorrhage. Crit Care Med 39:158-62
Weinstein, Jonathan R; Koerner, Ines P; Möller, Thomas (2010) Microglia in ischemic brain injury. Future Neurol 5:227-246
Creutzfeldt, Claire J; Becker, Kyra J; Longstreth Jr, W T et al. (2009) Platelet dysfunction in intraparenchymal hemorrhage. Stroke 40:e645; author reply e646